Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma - Concepedia

Concepedia

Publication | Open Access

Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma

DOI Full Paper Access

64

Citations

34

References

2016

Year

Néstor A. Molfino, Piotr Kuna, Jonathan A. Leff, Chad K. Oh, Dave Singh, Marlene Chernow, Brian J. Sutton, Geoffrey Yarranton

Abstract

NCT01603277; Results.

References

	Year	Citations

Page 1